Overview

Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients

Status:
Suspended
Trial end date:
2019-07-02
Target enrollment:
Participant gender:
Summary
Thrombosis occurring in the small intrahepatic, as well as in the large vessels is involved in the progression of cirrhosis. Anticoagulation could reduce morbidity and mortality in cirrhotic patients
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Dalteparin
Enoxaparin
Heparin
Heparin, Low-Molecular-Weight